Register to leave comments

  • News bot Aug. 11, 2026, 8:17 p.m.

    📋 CARDIFF ONCOLOGY, INC. (CRDF) - Financial Results

    Filing Date: 2026-08-11

    Accepted: 2026-08-11 16:11:16

    Event Type: Financial Results

    Event Details:

    CARDIFF ONCOLOGY, INC. (CRDF) Reports the reporting period Financial Results CARDIFF ONCOLOGY, INC. (CRDF) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 104
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 9197
      • targeting tumor vulnerabilities, we aim to overcome treatment resistance and deliver improved clinical outcomes for patients.For more information, please visit https://www.cardiffoncology.com.Forward-Looking StatementsCertain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Costs And Expenses Selling General Administrative 3.32K 9.93K $-6.61K -66.59%
    Costs And Expenses Loss From Operations 14.78K 22.46K $-7.69K -34.22%
    Other Income Expense Net Interest Income 835.00 888.00 $-53.00 -5.97%
    Other Income Expense Net Total Other Income Expense 834.00 888.00 $-54.00 -6.08%
    Other Income Expense Net Net Loss 13.94K 21.58K $-7.63K -35.38%
    Other Income Expense Net Net Loss Per Share 0.21 0.32 $-0.11 -34.38%
    Current Assets Prepaid Expenses Other Current Assets 883.00 1.64K $-759.00 -46.22%
    Current Assets Property Equipment Net 450.00 578.00 $-128.00 -22.15%
    Current Assets Operating Lease Right Of Use Assets 360.00 629.00 $-269.00 -42.77%
    Current Assets Other Assets 927.00 549.00 $378.00 +68.85%
    Current Liabilities Accounts Payable 3.99K 8.09K $-4.10K -50.71%
    Current Liabilities Accrued Liabilities 6.35K 7.58K $-1.22K -16.14%
    Current Liabilities Operating Lease Liabilities 457.00 730.00 $-273.00 -37.40%
    Revenue 104.00 121.00 $-17.00 -14.05%
    Selling, General & Administrative 3.80K 3.32K $486.00 +14.65%
    Loss from Operations 9.62K 14.78K $-5.16K -34.93%
    Interest Income 382.00 835.00 $-453.00 -54.25%
    Total Other Income/(Expense) 383.00 834.00 $-451.00 -54.08%
    Net Loss 9.23K 13.94K $-4.71K -33.79%
    Prepaid Expenses and Other Current Assets 883.00 1.64K $-759.00 -46.22%
    Property and Equipment, Net 450.00 578.00 $-128.00 -22.15%
    Other Assets 927.00 549.00 $378.00 +68.85%
    Accounts Payable 3.99K 8.09K $-4.10K -50.71%
    Accrued Liabilities 6.35K 7.58K $-1.22K -16.14%
    Operating Lease Liabilities 457.00 730.00 $-273.00 -37.40%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CARDIFF ONCOLOGY, INC.
    • Ticker Symbol: CRDF